课题基金 / 基金详情

Signal Transduction Pathways of Smooth Muscle

Signal Transduction Pathways of Smooth Muscle
平滑肌的信号转导途径
批准号:
6853376
负责人:
Avril V. Somlyo
金额:
$47.06万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-04-01 至 2009-03-31

项目摘要

项目成果

Avril V. Somlyo的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The overall Aim of this Project is to determine the physiologically relevant mechanisms of signal transduction that regulate contractility by pathways not dependent on cytoplasmic Ca concentration. The domain dependent functions of the upstream regulators of Ca?+-sensitization by the RhoA-Rho kinase pathway, the guanine nucleotide exchange factors (GEFs) PDZ.RhoGEF and LARG, will be determined in conjunction with the structural identification and recombinant expression of GEF domains in Project 2. The role of a membrane associated protein (p120 catenin) as a potential RhoA-binding partner guanine nucleotide dissociations inhibitor (GDI) will be determined. The kinetics of myosin phosphatase regulation by Rho-kinase and its dependence on the expression level of the endogenous phosphatase inhibitor, CP1-17 will be quantitated in order to determine their relative physiological relevance. The dependence of myosin phosphatase activity on the specific long and short splice isoforms of the regulatory subunit (MYPT1) expressed in mammalian smooth muscle will be evaluated, based on the hypothesis that expression levels of the ratio of the two isoforms determine localization of the phosphatase and the mechanism of its regulation through differences in their phosphorylation sites and myosin binding properties. A major, novel, objective of this Project is to determine the functions of a protein, LPP, newly discovered to be selectively expressed in smooth muscle, on cellular phenotypes, including morphology, adhesion to substrate, cytoskeletal structure and motility. Localization and stimulus induced translocation of signaling proteins, co-localization of proteins, such as p120 catenin with RhoA or CP1-17 with myosin phosphatase or telokin and telokin and LPP partners identified in two-hybrid screens will be performed in Project 3. p120 catenin, LPP, recombinant RhoA, telokin, RhoA- and other protein-mutants will be supplied by Core B. Abnormalities of the RhoA pathway are thought to be involved in asthma and hypertension.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Converge of Pathways Regulating SMC Contractility
  • 批准号:
    7541721
  • 项目类别:
  • 资助金额:
    $59.54万
  • 财政年份:
    2008
  • 负责人:
    Avril V. Somlyo
  • 依托单位:
Converge of Pathways Regulating SMC Contractility
  • 批准号:
    7333209
  • 项目类别:
  • 资助金额:
    $59.0万
  • 财政年份:
    2007
  • 负责人:
    Avril V. Somlyo
  • 依托单位:
Converge of Pathways Regulating SMC Contractility
  • 批准号:
    7312432
  • 项目类别:
  • 资助金额:
    $56.66万
  • 财政年份:
    2006
  • 负责人:
    Avril V. Somlyo
  • 依托单位:
Converge of Pathways Regulating SMC Contractility
  • 批准号:
    6967713
  • 项目类别:
  • 资助金额:
    $54.92万
  • 财政年份:
    2005
  • 负责人:
    Avril V. Somlyo
  • 依托单位:
海外基金